Target Price | $10.33 |
Price | $1.32 |
Potential |
682.83%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target Omega Therapeutics Inc 2025 .
The average Omega Therapeutics Inc target price is $10.33.
This is
682.83%
register free of charge
$12.00
809.09%
register free of charge
$6.00
354.55%
register free of charge
|
|
A rating was issued by 6 analysts: 6 Analysts recommend Omega Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Omega Therapeutics Inc stock has an average upside potential 2025 of
682.83%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 3.09 | 6.91 |
49.28% | 123.53% | |
EBITDA Margin | -3,025.57% | -911.91% |
35.82% | 69.86% | |
Net Margin | -3,212.62% | -904.53% |
43.65% | 71.84% |
7 Analysts have issued a sales forecast Omega Therapeutics Inc 2024 . The average Omega Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Omega Therapeutics Inc 2024 . The average Omega Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Omega Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Omega Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.80 | -1.13 |
15.89% | 37.22% | |
P/E | negative | |
EV/Sales | 22.23 |
7 Analysts have issued a Omega Therapeutics Inc forecast for earnings per share. The average Omega Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Omega Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Omega Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.